C9453 Nivolumab - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Nivolumab

Brand Name:

Opdivo

Strength:

1 mg

HCPCS:

C9453

SEER*Rx Category:

Immunotherapy

Major Drug Class:

Checkpoint Inhibitor

Minor Drug Class:

PD-1

Oral (Y/N):

No

FDA Approval Year:

2014

FDA Discontinuation Year:

CMS Effective Date:

July 1, 2015

CMS Discontinuation Date:

Status:

In Use